United States

the states
the US

OxyContin maker Purdue Pharma files for bankruptcy as part of opioids settlement

Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids.

The filing was anticipated before and after the tentative deal, which could be worth up to $12 billion over time, was struck.


Mixed reactions to U.S. move to ban flavoured e-cigarettes

A potential ban on flavoured e-cigarettes in the U.S. is a welcome step towards greater regulation of vaping products, says the Windsor-Essex County Health Unit.

“It’s encouraging to see federal governments start to have those types of conversations,” said Eric Nadalin, a manager in the WECHU’s health promotion department.

“Certainly, the concern with flavoured e-cigarettes is their attractiveness to youths. It’s something that we do want to acknowledge and develop protections against.”

On Wednesday, U.S. President Donald Trump announced a proposal for new enforcement policies by the Food and Drug Administration (FDA) that would effectively remove flavoured e-cigarettes from the U.S. vaping market.


Why pot's illicit history is making it so hard for companies to get patents in the legal cannabis era

When Canopy Growth Corp. announced a plan to acquire cannabis researcher Ebbu Inc. for US$330 million last October, it touted the company’s intellectual property as the primary reason for the deal, mentioning it five times in the short press release.

A year later, Canopy is struggling to turn that intellectual property into patents. One of Ebbu’s first applications was rejected twice by the U.S. Patent and Trademark Office. When it was then narrowed significantly in a renewed attempt at approval, it was rejected a third time.


Health Canada warns against modifying vape pens amid two deaths, spreading illness in U.S.

Health Canada says people who vape should get medical attention right away if they’re worried their electronic cigarettes are harming them.

The federal department says there is no sign in Canada of an affliction reported in as many as 25 American states that seems to be linked to vaping, but it is monitoring the situation.

Most of those who have fallen ill have been teens or adults in their 20s or 30s, hospitalized with severe shortness of breath, vomiting, fever and fatigue. Other symptoms include coughing, chest pain and diarrhea, and signs of infection, such as fevers, that appear without any apparent source.


What's with North Americans crossing the border with cannabis and getting in trouble?

Late last month, a Canadian woman faced a lifetime ban for attempting to cross the U.S. border with cannabidiol (CBD) oil in her possession — the decision was eventually overturned.


US and Canada cannabis market set to be worth over $47.3 billion by 2024

North America’s legal cannabis industry could be worth more than $47.3 (€43.23~) billion annually by 2024.

The North American Cannabis Report finds that despite Canada becoming the first G7 country to legalise adult-use cannabis, US cannabis market growth will greatly exceed its North American neighbour. Currently the most profitable industry in the world, the US, is expected to enjoy triple-digit growth by 2024, despite not having legalised cannabis on a federal scale.


U.S. reverses lifetime ban on Canadian woman who crossed border with CBD oil, her lawyer says

Less than two weeks after a Canadian woman was barred from entering the United States after she was found with cannabidiol (CBD) oil at the border, her lawyer says her lifetime ban from entering the states has been reversed in what he is calling a "best-case scenario."

The 21-year-old, who has asked not to be identified by CBC News, was crossing the border between B.C. and Washington state last month when CBD oil was found in her backpack.

CBD is a non-psychoactive product of the cannabis plant, and is used by the woman to treat the painful side-effects of scoliosis.


An in-depth breakdown of derivative cannabis sales in the U.S.

Last year, there was no shortage of marijuana milestones . We watched Canada become the first industrialized country in the world to legalize recreational marijuana, had the U.S. Food and Drug Administration (FDA) approve the very first cannabis-derived drug, and saw support for legalization among the U.S.


Here's how shockingly low the odds of U.S. marijuana legalization really are

Americans support legalizing marijuana in record numbers. A Hill-HarrisX survey released in April found that a whopping 84% of respondents support the legalization of pot. Half were in favor only for legalizing medical cannabis, with the other half supportive of legalizing the recreational use of marijuana as well.

With this widespread support, you might assume that U.S. marijuana legalization is a shoo-in. Think again.

By my rough calculations, the odds of marijuana being legalized in the U.S. within the next few years is less than 1 in 300. That's right: The chances that you would flip a coin and have it land on heads eight times in a row are much better than the country legalizing pot anytime soon.


Subscribe to RSS - United States